SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-16-096775
Filing Date
2016-04-28
Accepted
2016-04-28 09:17:24
Documents
6
Period of Report
2016-04-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v438144_8k.htm 8-K 37287
2 EXHIBIT 2.1 v438144_ex2-1.htm EX-2.1 699656
3 EXHIBIT 10.28 v438144_ex10-28.htm EX-10.28 66733
4 EXHIBIT 10.29 v438144_ex10-29.htm EX-10.29 42184
5 EXHIBIT 10.30 v438144_ex10-30.htm EX-10.30 59564
6 EXHIBIT 99.1 v438144_ex99-1.htm EX-99.1 21950
  Complete submission text file 0001144204-16-096775.txt   928604
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35366 | Film No.: 161597396
SIC: 2834 Pharmaceutical Preparations